Home DailyMed 7c0923ad-80b0-4134-b44a-754ea599f356 Oseltamivir Phosphate for Oral Suspension Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer Zydus Lifesciences Limited
Effective date 2024-12-09
Label type HUMAN PRESCRIPTION DRUG LABEL
Version 5
Source full-release
Hydrated at 2026-05-31 21:19:05 Label at a glance# Product Oseltamivir Phosphate
Active ingredient OSELTAMIVIR PHOSPHATE
Label structure 1 sections
DailyMed RxNorm Mappings# RxCUI, RxNorm string, TTY table RxCUI RxNorm string TTY SPL version 1115698 oseltamivir phosphate 6 MG in 1 mL Oral Suspension PSN 5 1115698 oseltamivir 6 MG/ML Oral Suspension SCD 5 1115698 oseltamivir (as oseltamivir phosphate) 6 MG/ML Oral Suspension SY 5 1115698 oseltamivir phosphate 6 MG per 1 ML Oral Suspension SY 5
DailyMed Pharmacologic Classes# DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70771-1598-6 Oseltamivir Phosphate 60 mL in 1 BOTTLE SUSPENSION 60 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70771-1598 OSELTAMIVIR PHOSPHATE (OSELTAMIVIR ACID) SUSPENSION [ZYDUS LIFESCIENCES LIMITED] 5 Current NDC, Legacy NDC, 1 package rows 20241210_7c0923ad-80b0-4134-b44a-754ea599f356.zip
Products# Every source-derived product name is available through these pages.
DailyMed product names page 1 of 1 · 9 matching rows.
Oseltamivir Phosphate Oseltamivir Acid MONOSODIUM CITRATE SACCHARIN SODIUM SODIUM BENZOATE SORBITOL TITANIUM DIOXIDE WATER XANTHAN GUM Ingredients# Every source-derived ingredient row is available through these pages.
DailyMed ingredient rows page 1 of 1 · 8 matching rows.
Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A209113-001 OSELTAMIVIR PHOSPHATE OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A209113-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 c2088c7a36db…2026-09-14 22:38:34 2026-08 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 84e616aacf4f…2026-08-18 06:07:40 2026-07 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A209113-001 OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB 2017-09-14 3a93d1ddd44b…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 44 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.